Lincare Holdings reiterated as top mid-cap idea at Citigroup
Citigroup believes the Senate's healthcare reform bill makes it unlikely that oxygen reimbursement rates will be reduced during the next 3-4 years. The firm expects Lincare's valuation to expand materially if that holds true and reiterates the stock as a top mid-cap idea. :theflyonthewall.com
News For LNCR From The Last 14 Days
Check below for free stories on LNCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
